|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��Ƥ�ʼ�����,���� |
|
Ƥ��,ҩ�︱��Ӧ |
| ��������������� | |
|
������ |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
��Ƥ�ʼ�����Ƥ���о���չ
������, ����
�����е�������ҽԺƤ����, 310009
���ڲ��ʵ�������Ƥ�ʼ����������Ƥ�ʼ�����Ƥ�ķ�������������,����ΪƤ�����졢���ή���䱡��ëϸѪ�����š���м���������������Ƥ���,�����ȡ���ʹ�����������������,ͣ����Ƥ�ʼ��غ�����ַ�������Ϊ��,�����й���Ƥ�ʼ�����Ƥ�IJ��������ơ��ٴ��ص㡢��֯�����������Լ�顢��ϼ����Ƶȡ�
[2] Fume M, Terao H, Rikihisa W, et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol, 2003, 148:128-133.
[3] Kolbe L, Kligman AM, Schreiner V, etal. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol, 2001,7:73-77.
[4] Kao JS, Fluhr JW, Man MQ, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity:inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol, 2003, 120:456-464.
[5] Fluhr JW, Kao J, Jain M, et al. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity.J Invest Dermatol, 2001, 117:44-51.
[6] Coderch L, Lopez O, de la Maza A, et al. Ceramides and skin function. Am J Clin Dermatol, 2003,4:107-129.
[7] Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology:clinical pharmacology and therapeutic use.Am J Clin Dermatol, 2002, 3:47-58.
[8] Fisher DA. Adverse effects of topical corticosteroid use. West J Med, 1995, 162:123-126.
[9] Erbagci Z, Ozgoztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol, 1998, 37:421-425.
[10] Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol, 1993, 28:443-448.
[11] Zheng PS, Lavker RM, Lehmann P, et al. Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin. J Invest Dermatol, 1984, 82:345-352.
[12] Guin JD. Complications of topical hydrocortisone. J Am Acad Dermatol, 1981, 4:417-422.
[13] Man MQ M, Feingold KR, Thornfeldt CR,et al. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol,1996,106:1096-1101.
[14] Pasonen-Seppanen S, Suhonen TM, Kirjavainen M, et al. Vitamin C enhances differentiation of a continuous keratinocyte cell line(REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier. Histochem Cell Biol, 2001,116:287-297.
[15] Tanno O, Ota Y, Kitamura N, et al. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol, 2000, 143:524-531.